4//SEC Filing
MPM BIOVENTURES 2018, L.P. 4
Accession 0001415889-25-013251
CIK 0001808865other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 5:33 PM ET
Size
10.7 KB
Accession
0001415889-25-013251
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2025-05-13$8.06/sh−630,191$5,079,339→ 2,108,594 total(indirect: See Footnote)
Transactions
- Sale
Common Stock
2025-05-13$8.06/sh−630,191$5,079,339→ 2,108,594 total(indirect: See Footnote)
Transactions
- Sale
Common Stock
2025-05-13$8.06/sh−630,191$5,079,339→ 2,108,594 total(indirect: See Footnote)
Footnotes (3)
- [F1]The shares were sold as follows: 355,406 by MPM BioVentures 2014, L.P. ("BV 2014"), 22,386 by MPM BioVentures 2014 (B), L.P. ("BV 2014(B)"), 12,233 by MPM Asset Management Investors BV2014 LLC ("AM BV2014"), 224,467 by MPM BioVentures 2018, L.P. ("BV 2018"), 11,267 by MPM BioVentures 2018(B), L.P. ("BV 2018(B)") and 4,432 by MPM Asset Management Investors BV2018 LLC ("AM BV2018"). MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV 2014 LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). BV 2014 LLC is the manager of AM BV2014. MPM BioVentures 2018 GP LLC and MPM BioVentures 2018 LLC ("BV 2018 LLC") are the direct and indirect general partners of BV 2018 and BV 2018(B). BV 2018 LLC is the manager of AM BV2018. Messrs. Evnin and Foley are managing directors of BV 2014 LLC and BV 2018 LLC.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.73 to $8.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The shares are held as follows: 1,189,174 by BV 2014, 74,903 by BV 2014(B), 40,931 by AM BV2014, 751,056 by BV 2018, 37,699 by BV 2018(B) and 14,831 by AM BV2018. Each of the Reporting Persons disclaims beneficial ownership of the securities herein except to the extent of his or its respective pecuniary interest therein, if any.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001729505
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 5:33 PM ET
- Size
- 10.7 KB